DATATRAK International, Inc. Reports Audited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2018
March 20, 2019 at 01:45 pm EDT
Share
DATATRAK International, Inc. reported audited consolidated earnings results for the fourth quarter and full year ended December 31, 2018. For the quarter, the company's revenue was $1,914,763 compared to $1,928,404 a year ago. Income from operations was $21,292 compared to $338,469 a year ago. Net income was $19,658 compared to $473,359 a year ago. Basic net income per share was $0.01 compared to $0.21 a year ago.
For the year, the company's revenue was $7,447,356 compared to $7,524,043 a year ago. Income from operations was $160,725 compared to $212,207 a year ago. Net income was $161,575 compared to $219,696 a year ago. Basic net income per share was $0.07 compared to $0.11 a year ago.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.
DATATRAK INTERNATIONAL, INC. 
